Company intelligence
Cleerly
Personalized precision heart health
About Cleerly
Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease. Through its AI-empowered solutions, Cleerly supports comprehensive phenotyping of coronary artery disease, through its evaluation of advanced non-invasive CT imaging. Cleerly’s approach is grounded in nearly 20 years of science from landmark multi-center clinical trials. Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway.
Verified activity
Signals from Cleerly
6 published signals
Presence & Recognition
Cleerly hosted a virtual symposium featuring leading experts from the American Society for Preventive Cardiology (ASPC) on cardiovascular disease and women's heart health.
Reported by Cleerly
People
Cleerly welcomed Mikayla Scott to the team.
Reported by Mikayla Scott, BSN, RN, MMCi
Presence & Recognition
Cleerly announced updates to its CTA recommendations.
Reported by Patrick Mac
Presence & Recognition
Cleerly has been nominated for the 2026 Prix Galien Award in the Best Digital Health Solution category for Cleerly LABS.
Reported by Cleerly
Presence & Recognition
Cleerly hosted a webinar featuring Dr. Kevin Young discussing real-world cases using Cleerly COMPARE, an AI-generated reporting tool combining CCTA with expert reader review.
Reported by Cleerly
Products & Services
Cleerly introducedCOMPARE, a unique feature combining CCTA with AI-generated reporting to allow longitudinal assessment and personalization of CAD care.
Reported by Patrick Mac